Roche Holding AG
SIX:ROG
Roche Holding AG
Other Current Liabilities
Roche Holding AG
Other Current Liabilities Peer Comparison
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Roche Holding AG
SIX:ROG
|
Other Current Liabilities
CHf16.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
4%
|
|
Novartis AG
SIX:NOVN
|
Other Current Liabilities
$16.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
2%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Other Current Liabilities
$5.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Other Current Liabilities?
Other Current Liabilities
16.1B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Other Current Liabilities amounts to 16.1B CHF.
What is Roche Holding AG's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
4%
Over the last year, the Other Current Liabilities growth was -14%. The average annual Other Current Liabilities growth rates for Roche Holding AG have been -2% over the past three years , -1% over the past five years , and 4% over the past ten years .